top of page

PADCEV ~ enfortumab vedotin-eifv ~ SEPT 29th ~ Don't miss it!

Updated: Sep 16, 2020

YOU ARE CORDIALLY INVITED TO A VIRTUAL PROGRAM A program on an FDA-approved treatment option in locally advanced or mUC for patients who have previously received a PD-1 or PD-L1 inhibitor and a platinum- containing chemotherapy in the neoadjuvant/adjuvant, locally advanced, or metastatic setting.

PRESENTER Bethany Mooney, RNP Medical Oncology Nurse Practitioner Penn Medicine Philadelphia, PA

LOCATION Register in advance for this meeting: Link: Meeting Registration After registering, you will receive a confirmation email containing information about joining the meeting.

Kindly Reply by 09/22/2020 In the RSVP, please include your Name, Contact Information, Organization, and Specialty.

31 views0 comments

Recent Posts

See All

Cancer Equity Colloquium 2024

Now more than ever, the presence of social inequities in healthcare is evident. This two-day, hybrid event, the Cancer Equity Colloquium, will address the diverse issues that underlie cancer inequitie


bottom of page